{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/zh-Hant/reddit/r/stocks/comments/malrnv/pharma_stocks_are_as_cheap_as_theyve_been_in_the/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","description":"用中文浏览国外股票社区里的热门讨论","social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true,"prefetch":null},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true,"prefetch":null},{"name":"Reddit Bogleheads","url":"https://www.reddit.com/r/Bogleheads/","external":true,"prefetch":null},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true,"prefetch":null}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null,"prefetch":null}],"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","locale":"en","social":[{"name":"Reddit","url":"https://www.reddit.com/","external":true,"prefetch":null}],"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null,"prefetch":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null,"prefetch":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","locale":"ja","social":null,"menuLinks":[{"name":"每週精選","url":"/ja/issues","external":null,"prefetch":null}]}]}},"blogPost":{"__typename":"SocialMediaPost","id":"RedditPost-malrnv","excerpt":"The drug P/E ratio is one of the lowest among any major industry group, so much\nso that pharma stocks haven’t been so inexpensive relative to the S&P 500 in at\nleast 20 years. Many pharmaceutical stocks are trading with a forward PE ratio\nranging from 12 to 7,5. Abbvie has a forward PE of 7,5, Merck…","body":"<!-- SC_OFF --><div class=\"md\"><p>The drug P/E ratio is one of the lowest among any major industry group, so much so that pharma stocks haven’t been so inexpensive relative to the S&amp;P 500 in at least 20 years. Many pharmaceutical stocks are trading with a forward PE ratio ranging from 12 to 7,5. Abbvie has a forward PE of 7,5, Merck is at 11,5, Bristol Myers Squibb at 8, Novartis as well is trading at 12 forward PE. They all boast a 3-4% dividend yield and EPS growth forecasted between 7-10%. I do not see many downsides in investing in these companies, beside some patents expiration down the line. Despite the great cash flow and valuations this sector seems to be lagging. Why do you think it is so? In such an expensive market to see a company like Merck trade at 11 forward PE seems too good to be true, and I&#39;d like to hear your opinion.</p>\n</div><!-- SC_ON -->","slug":"/reddit/r/stocks/comments/malrnv/pharma_stocks_are_as_cheap_as_theyve_been_in_the/","title":"Pharma stocks are as cheap as they've been in the past 20 years. Why?","tags":["stocks","reddit"],"date":"March 22, 2021","dateISO":"2021-03-22T16:40:09.000Z","datetime":"2021-03-22 16:40","image":null,"imageAlt":null,"socialImage":null,"fields":{"basePath":"/"},"thirdPartyId":"malrnv","provider":"Reddit","url":"https://www.reddit.com/r/stocks/comments/malrnv/pharma_stocks_are_as_cheap_as_theyve_been_in_the/","originalUrl":"https://www.reddit.com/r/stocks/comments/malrnv/pharma_stocks_are_as_cheap_as_theyve_been_in_the/","imageRemote":null,"video":null,"channel":"stocks","channelUrl":"https://www.reddit.com/r/stocks","author":"msquared_ita","authorUrl":"https://www.reddit.com/user/msquared_ita","authorImage":null,"authorSlug":"msquared_ita","score":115,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"__typename":"RedditJson","localize":[{"title":"医药股是过去20年来最便宜的。为什么这么说？","the_new_excerpt":"药品的市盈率在各大行业集团中是最低的，如此一来\n所以，制药股相对于标准普尔500指数来说，并没有那么便宜，在这一点上，制药股的价格是很高的。\n至少20年。许多医药股的交易远期PE值为\n从12到7. 5不等 Abbvie的远期PE为7,5，Merck...","locale":"zh"},{"title":"醫藥股是過去20年來最便宜的。爲什麼這麼說？","the_new_excerpt":"藥品的市盈率在各大行業集團中是最低的，如此一來\n所以，製藥股相對於標準普爾500指數來說，並沒有那麼便宜，在這一點上，製藥股的價格是很高的。\n至少20年。許多醫藥股的交易遠期PE值爲\n從12到7. 5不等 Abbvie的遠期PE爲7,5，Merck...","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-mrcp5k","excerpt":"Good Morning Everyone!","slug":"/reddit/r/wallstreetbets/comments/mrcp5k/gme_megathread_for_april_15_2021/","title":"GME Megathread for April 15, 2021","date":"April 15, 2021","__typename":"SocialMediaPost","parent":{"__typename":"RedditJson","localize":[{"title":"2021年4月15日のGME Megathread","the_new_excerpt":"皆さん、おはようございます。","locale":"ja"},{"title":"2021年4月15日的全球环境监测系统Megathread。","the_new_excerpt":"大家早上好","locale":"zh"},{"title":"2021年4月15日的全球環境監測系統Megathread。","the_new_excerpt":"大家早上好","locale":"zh-Hant"}]}},"next":{"id":"RedditPost-mr9li4","excerpt":"Bloomberg via Yahoo Finance\n[https://finance.yahoo.com/news/tsmc-profit-beats-chip-shortage-053347899.html]\n\nSome highlights:\n\n> The world’s largest contract chipmaker said Thursday that its automaker\n> industry clients can expect chip shortages to begin easing next quarter,\n> alleviating some of…","slug":"/reddit/r/stocks/comments/mr9li4/tsmc_earnings_q1_profit_rises_19_revenues_254/","title":"TSMC Earnings: Q1 profit rises 19%, revenues +25.4%, 2021 expansion spending to reach $30 billion","__typename":"SocialMediaPost","date":"April 15, 2021","parent":{"__typename":"RedditJson","localize":[{"title":"TSMCの決算。第1四半期の利益は19%増、売上高は25.4%増、2021年の拡張支出は300億ドルに達する見込み","the_new_excerpt":"ブルームバーグ via Yahoo ファイナンス\n[https://finance.yahoo.com/news/tsmc-profit-beats-chip-shortage-053347899.html]\n\nいくつかのハイライトをご紹介します。\n\n> 世界最大の契約チップメーカーは木曜日、自動車メーカーの\n> 世界最大の契約チップメーカーは、自動車メーカーの顧客が次の四半期にはチップ不足が解消されると期待できると述べた。\n> これにより、自動車業界の顧客は","locale":"ja"},{"title":"台积电财报。一季度利润增长19%，营收+25.4%，2021年扩张支出将达300亿美元","the_new_excerpt":"彭博社通过雅虎财经\n[https://finance.yahoo.com/news/tsmc-profit-beats-chip-shortage-053347899.html]\n\n一些亮点。\n\n> 全球最大的合同芯片制造商周四表示，其汽车制造商\n>行业客户可以预期下一季度芯片短缺将开始缓解。\n> 缓解一些...","locale":"zh"},{"title":"臺積電財報。一季度利潤增長19%，營收+25.4%，2021年擴張支出將達300億美元","the_new_excerpt":"彭博社通過雅虎財經\n[https://finance.yahoo.com/news/tsmc-profit-beats-chip-shortage-053347899.html]\n\n一些亮點。\n\n> 全球最大的合同芯片製造商週四表示，其汽車製造商\n>行業客戶可以預期下一季度芯片短缺將開始緩解。\n> 緩解一些...","locale":"zh-Hant"}]}}},"pageContext":{"id":"RedditPost-malrnv","previousId":"RedditPost-mrcp5k","nextId":"RedditPost-mr9li4","maxWidth":1024,"locale":"zh-Hant","hrefLang":"zh-Hant","originalPath":"/reddit/r/stocks/comments/malrnv/pharma_stocks_are_as_cheap_as_theyve_been_in_the/","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2506312863","2744905544","3493603132","3493603132","3513215887","386998304"]}